株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

スマートピル市場 - 成長、傾向、および予測(2019年 - 2024年)

Smart Pills Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 871419
出版日 ページ情報 英文 111 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
スマートピル市場 - 成長、傾向、および予測(2019年 - 2024年) Smart Pills Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 111 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

当レポートでは世界のスマートピル市場について調査しており、市場概況や成長要因・阻害要因、用途分野・病気の徴候・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

  • 研究成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 低侵襲装置の選択増加
    • 消化器疾患の発生率の増加
    • 技術進歩
  • 市場阻害要因
    • 技術進歩によるコストの増加
    • 潜在的な健康上のリスク
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界の競争

第5章 市場セグメント

  • 用途分野別
    • カプセル内視鏡
    • 患者モニタリング
    • ドラッグデリバリー
  • 病気の徴候別
    • 原因不明の消化管出血
    • クローン病
    • 小腸腫瘍
    • セリアック病
    • 遺伝性ポリポーシス症候群
    • 神経障害
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東とアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Boston Scientific Corporation
    • GE Healthcare
    • Given Imaging Ltd
    • Microchips
    • Novartis AG
    • オリンパス株式会社
    • Phillips
    • Pixie Scientific
    • Proteus Pharmaceuticals
    • Vitality

第7章 市場機会および今後の動向

目次
Product Code: 56614

Market Overview

A smart drug delivery pill is controlled by electronics and has great flexibility and precise control in delivery location, release rate, and dose. At the same time, it can monitor the local GI environment, report measurements in real time, and be commanded by an operator to perform an action on demand. This type of performance is impossible with conventional oral drug forms. While there are myriad therapeutic implications, the system can also be viewed from the direction of a smart tool that can be employed to great advantage in drug development of more conventional oral drug products. A smart pill is a medical device with a small embedded electronic product such as a camera, sensors, or trackers. The increased need for convenient, minimally invasive devices and accurate therapeutic treatment strategies has led to an increased interest in research on smart pills.

Products include the Medtronic MiniMed, Insulet Omnipod, and Animas OneTouch Ping. These systems combine elements of a drug reservoir, insulin pump, blood glucose monitor, and handheld management device. Delivery of insulin is adapted to the patient's current blood glucose level and may be delivered on demand by the patient, for example at mealtime. Similar is the emerging area of wearable bolus injection devices.

Scope of the Report

As per the scope of the report, smart pills are ingestible medical devices consisting of elements, such as sensors, cameras, patches, and trackers that help in better diagnostics and monitoring. These unique devices can be easily swallowed and offer a non-invasive, thorough examination of the gastrointestinal (GI) tract.

Key Market Trends

Capsule Endoscopy is Expected to Hold Largest Share of Global Smart Pills Market, Over the forecast period

The most common so far is targeting the small bowel, it is seen as a gold standard if GI bleeding is suspected. Also, Currently, most hepatologists perform either upper endoscopy or capsule endoscopy for detecting and assessing the severity of esophageal varices. Different capsules enlarge the variety of utilization and diagnostics. Capsule Endoscopy has the largest share in the market as these smart pills are highly used to related disease to the GI Tract which includes Crohn's disease, obscure GI bleed, celiac disease, and small bowel tumors. Furthermore, increasing prevalence of gastrointestinal disorders is also anticipated to fuel the market over the forecast period.

North America Region Holds the Largest Market Share of Smart Pills Market

North America dominates the Smart Pills market, owing to factors such as technological advancements in the healthcare sector, an increase in the prevalence of colorectal cancer and regulatory approval of new products. All these factors are responsible to provide the growth opportunities for the players operating in this region.

Competitive Landscape

The market competition is set to intensify as several key players are focusing on the expansion of their Smart Pills portfolio through acquisition and collaboration with companies. The Smart Pills market is expected to open up several opportunities for new players as well as currently established market leaders.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Minimally-invasive Device
    • 4.2.2 Increasing Incidence of Gastrointestinal Disorders
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Increasing Cost with Technological Advancements
    • 4.3.2 Potential Health Risks
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Application Area
    • 5.1.1 Capsule Endoscopy
      • 5.1.1.1 Small Bowel Video Capsule Endoscopy
      • 5.1.1.2 Colon Capsule Endoscopy
    • 5.1.2 Patient Monitoring
    • 5.1.3 Drug Delivery
  • 5.2 By Disease Indication
    • 5.2.1 Occult GI Bleeding
    • 5.2.2 Crohn's Disease
    • 5.2.3 Small Bowel Tumors
    • 5.2.4 Celiac Disease
    • 5.2.5 Inherited Polyposis Syndromes
    • 5.2.6 Neurological Disorders
    • 5.2.7 Other Disease Indications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 GE Healthcare
    • 6.1.3 Given Imaging Ltd
    • 6.1.4 Microchips
    • 6.1.5 Novartis AG
    • 6.1.6 Olympus Medical Technology
    • 6.1.7 Phillips
    • 6.1.8 Pixie Scientific
    • 6.1.9 Proteus Pharmaceuticals
    • 6.1.10 Vitality

7 MARKET OPPORTUNITIES AND FUTURE TRENDS